| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |